{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:23:45Z","timestamp":1777663425551,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1724-7","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T14:07:51Z","timestamp":1471874871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology"],"prefix":"10.1186","volume":"16","author":[{"given":"Aurelio","family":"Cafaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Piccaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Gigantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Matarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Ferrantelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Ensoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/320367a0","volume":"320","author":"AG Fisher","year":"1986","unstructured":"Fisher AG, Feinberg MB, Josephs SF, Harper ME, Marselle LM, Reyes G, et al. The trans-activator gene of HTLV-III is essential for virus replication. Nature. 1986;320:367\u201371.","journal-title":"Nature"},{"key":"1724_CR2","first-page":"208","volume":"1","author":"HK Chang","year":"1994","unstructured":"Chang HK, Gendelman R, Lisziewicz J, Gallo RC, Ensoli B. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1. Gene Ther. 1994;1:208\u201316.","journal-title":"Gene Ther"},{"key":"1724_CR3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1061548","volume":"293","author":"Y Wu","year":"2001","unstructured":"Wu Y, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science. 2001;293:1503\u20136.","journal-title":"Science"},{"key":"1724_CR4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/345084a0","volume":"345","author":"B Ensoli","year":"1990","unstructured":"Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi\u2019s sarcoma lesions of AIDS patients. Nature. 1990;345:84\u20136.","journal-title":"Nature"},{"key":"1724_CR5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/375497a0","volume":"375","author":"MO Westendorp","year":"1995","unstructured":"Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 1995;375:497\u2013500.","journal-title":"Nature"},{"key":"1724_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152612798994939","volume":"12","author":"S Mediouni","year":"2012","unstructured":"Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H, et al. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus Tat protein. Infect Disord Drug Targets. 2012;12:81\u20136.","journal-title":"Infect Disord Drug Targets"},{"key":"1724_CR7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/371674a0","volume":"371","author":"B Ensoli","year":"1994","unstructured":"Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994;371:674\u201380.","journal-title":"Nature"},{"key":"1724_CR8","doi-asserted-by":"publisher","unstructured":"Cafaro A, Tripiciano A, Sgadari C, Bellino S, Picconi O, Longo O, et al. Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine. Expert Opin Biol Ther 2015;1\u201317. doi: 10.1517\/14712598.2015.1021328 .","DOI":"10.1517\/14712598.2015.1021328"},{"key":"1724_CR9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","volume":"275","author":"M Ott","year":"1997","unstructured":"Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, et al. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science. 1997;275:1481\u20135.","journal-title":"Science"},{"key":"1724_CR10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/9488","volume":"5","author":"A Cafaro","year":"1999","unstructured":"Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med. 1999;5:643\u201350.","journal-title":"Nat Med"},{"key":"1724_CR11","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.00377-10","volume":"84","author":"A Cafaro","year":"2010","unstructured":"Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, et al. Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian\/human immunodeficiency virus SHIV89.6P. J Virol. 2010;84:8953\u20138.","journal-title":"J Virol"},{"key":"1724_CR12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/QAD.0b013e32831392d4","volume":"22","author":"B Ensoli","year":"2008","unstructured":"Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, et al. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein. AIDS. 2008;22:2207\u20139.","journal-title":"AIDS"},{"key":"1724_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vaccine.2009.10.038","volume":"28","author":"B Ensoli","year":"2009","unstructured":"Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, et al. The preventive phase I trial with the HIV-1 Tat-based vaccine. Vaccine. 2009;28:371\u20138.","journal-title":"Vaccine"},{"key":"1724_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013540","volume":"5","author":"B Ensoli","year":"2010","unstructured":"Ensoli B, Bellino S, Tripiciano A, Longo O, Francavilla V, Marcotullio S, et al. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. PLoS One. 2010;5, e13540. doi: 10.1371\/journal.pone.0013540 .","journal-title":"PLoS One"},{"key":"1724_CR15","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/j.vaccine.2009.01.090","volume":"27","author":"O Longo","year":"2009","unstructured":"Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine. 2009;27:3306\u201312.","journal-title":"Vaccine"},{"key":"1724_CR16","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.0611244104","volume":"104","author":"A S\u00e1ez-Ciri\u00f3n","year":"2007","unstructured":"S\u00e1ez-Ciri\u00f3n A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA. 2007;104:6776\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1724_CR17","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","volume":"182","author":"A S\u00e1ez-Ciri\u00f3n","year":"2009","unstructured":"S\u00e1ez-Ciri\u00f3n A, Sinet M, Shin SY, Urrutia A, Lacabaratz C, Versmisse P, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 2009;182:7828\u201337.","journal-title":"J Immunol"},{"key":"1724_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12977-015-0151-y","volume":"12","author":"F Ensoli","year":"2015","unstructured":"Ensoli F, Cafaro A, Casabianca A, Tripiciano A, Bellino S, Longo O, et al. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. Retrovirol. 2015;12:33. doi: 10.1186\/s12977-015-0151-y .","journal-title":"Retrovirol"},{"key":"1724_CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/605930","volume":"200","author":"K Middelkoop","year":"2009","unstructured":"Middelkoop K, Bekker LG, Mathema B, Shashkina E, Kurepina N, Whitelaw A, et al. Molecular epidemiology of Mycobacterium tuberculosis in South African community with high HIV prevalence. J Infect Dis. 2009;200:1207\u201311.","journal-title":"J Infect Dis"},{"key":"1724_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.168.1.197","volume":"168","author":"E Fanales-Belasio","year":"2002","unstructured":"Fanales-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A, Ensoli B. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J Immunol. 2002;168:197\u2013206.","journal-title":"J Immunol"},{"key":"1724_CR21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1462-5822.2007.00884.x","volume":"9","author":"C Palma","year":"2007","unstructured":"Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, et al. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Cell Microbiol. 2007;9:1455\u201365.","journal-title":"Cell Microbiol"},{"key":"1724_CR22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/378412","volume":"188","author":"S Butt\u00f2","year":"2003","unstructured":"Butt\u00f2 S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, et al. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. J Infect Dis. 2003;188:1171\u201380.","journal-title":"J Infect Dis"},{"key":"1724_CR23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","volume":"182","author":"NP Juffermans","year":"2000","unstructured":"Juffermans NP, Florquin S, Camoglio L, Verbon A, Kolk AH, Speelman P, et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis. 2000;182:902\u20138.","journal-title":"J Infect Dis"},{"key":"1724_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ni.2474","volume":"14","author":"BB Mishra","year":"2013","unstructured":"Mishra BB, Rathinam VA, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA, Sassetti CM. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1\u03b2. Nat Immunol. 2013;14:52\u201360.","journal-title":"Nat Immunol"},{"key":"1724_CR25","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","volume":"184","author":"KD Mayer-Barber","year":"2010","unstructured":"Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, et al. Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 2010;184:3326\u201330.","journal-title":"J Immunol"},{"key":"1724_CR26","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178:2249\u201354.","journal-title":"J Exp Med"},{"key":"1724_CR27","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","volume":"364","author":"SE Dorman","year":"2004","unstructured":"Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364:2113\u201321.","journal-title":"Lancet"},{"key":"1724_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader SA, Bell K, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8:369\u201377.","journal-title":"Nat Immunol"},{"key":"1724_CR29","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","volume":"29","author":"JT Dissel van","year":"2011","unstructured":"van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, et al. Ag85B-ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine. 2011;29:2100\u20139.","journal-title":"Vaccine"},{"key":"1724_CR30","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","volume":"69","author":"A Weinrich Olsen","year":"2001","unstructured":"Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and esat-6. Infect Immun. 2001;69:2773\u20138.","journal-title":"Infect Immun"},{"key":"1724_CR31","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.vaccine.2008.05.050","volume":"26","author":"C Palma","year":"2008","unstructured":"Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Fattorini L, et al. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-\u03b3 response. Vaccine. 2008;26:4237\u201343.","journal-title":"Vaccine"},{"key":"1724_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048781","volume":"7","author":"P Monini","year":"2012","unstructured":"Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, et al. HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies. PLoS One. 2012;7, e48781. doi: 10.1371\/journal.pone.0048781 .","journal-title":"PLoS One"},{"key":"1724_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041205","volume":"7","author":"L Ignatowicz","year":"2012","unstructured":"Ignatowicz L, Mazurek J, Leepiyasakulchai C, Sk\u00f6ld M, Hinkula J, K\u00e4llenius G, Pawlowski A. Mycobacterium tuberculosis infection interferes with HIV vaccination in mice. PLoS One. 2012;7, e41205. doi: 10.1371\/journal.pone.0041205 .","journal-title":"PLoS One"},{"key":"1724_CR34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1874613601105010086","volume":"5","author":"JR Honda","year":"2011","unstructured":"Honda JR, Shang S, Shanley CA, Caraway ML, Henao-Tamayo M, Chan ED, et al. Immune responses of HIV-1 tat transgenic mice to Mycobacterium tuberculosis W-Beijng SA161. Open AIDS J. 2011;5:86\u201395.","journal-title":"Open AIDS J"},{"key":"1724_CR35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","volume":"22","author":"RJ North","year":"2004","unstructured":"North RJ, Jung YJ. Immunity to Tuberculosis. Annu Rev Immunol. 2004;22:599\u2013623.","journal-title":"Annu Rev Immunol"},{"key":"1724_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003472","volume":"9","author":"L Kozakiewicz","year":"2013","unstructured":"Kozakiewicz L, Chen Y, Xu J, Wang Y, Dunussi-Joannopoulos K, Ou Q, et al. B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog. 2013;9, e1003472. doi: 10.1371\/journal.ppat.1003472 .","journal-title":"PLoS Pathog"},{"key":"1724_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.09-0903","volume":"137","author":"SY Eum","year":"2010","unstructured":"Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, Hwang SH, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2010;137:122\u20138.","journal-title":"Chest"},{"key":"1724_CR38","first-page":"818","volume":"9","author":"R Ribeiro-Rodrigues","year":"2002","unstructured":"Ribeiro-Rodrigues R, Resende T, Johnson JL, Ribeiro F, Palaci M, S\u00e1 RT, et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol. 2002;9:818\u201323.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1724_CR39","doi-asserted-by":"publisher","first-page":"g4643","DOI":"10.1136\/bmj.g4643","volume":"349","author":"A Roy","year":"2014","unstructured":"Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ. 2014;349:g4643. doi: 10.1136\/bmj.g4643 .","journal-title":"BMJ"},{"key":"1724_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","volume":"378","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378:57\u201372.","journal-title":"Lancet"},{"key":"1724_CR41","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4049\/jimmunol.0711406","volume":"182","author":"E Fanales-Belasio","year":"2009","unstructured":"Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone Cossut MR, et al. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol. 2009;182:2888\u201397.","journal-title":"J Immunol"},{"key":"1724_CR42","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.173.6.3838","volume":"173","author":"R Gavioli","year":"2004","unstructured":"Gavioli R, Gallerani E, Fortini C, Fabris M, Bottoni A, Canella A, et al. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J Immunol. 2004;173:3838\u201343.","journal-title":"J Immunol"},{"key":"1724_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077746","volume":"8","author":"F Nicoli","year":"2013","unstructured":"Nicoli F, Finessi V, Sicurella M, Rizzotto L, Gallerani E, Destro F, et al. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. PLoS One. 2013;8, e77746. doi: 10.1371\/journal.pone.0077746 .","journal-title":"PLoS One"},{"key":"1724_CR44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/QAD.0000000000000315","volume":"28","author":"F Sforza","year":"2014","unstructured":"Sforza F, Nicoli F, Gallerani E, Finessi V, Reali E, Cafaro A, et al. HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors. AIDS. 2014;28:1729\u201338.","journal-title":"AIDS"},{"key":"1724_CR45","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","volume":"110","author":"TP Johnson","year":"2013","unstructured":"Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci USA. 2013;110:13588\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1724_CR46","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/eji.201243245","volume":"43","author":"C Palma","year":"2013","unstructured":"Palma C, Schiavoni G, Abalsamo L, Mattei F, Piccaro G, Sanchez M, et al. Mycobacterium tuberculosis PstS1 amplifies IFN-\u03b3 and induces IL-17\/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation. Eur J Immunol. 2013;43:2386\u201397.","journal-title":"Eur J Immunol"},{"key":"1724_CR47","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.1202688","volume":"190","author":"P Jayaraman","year":"2013","unstructured":"Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. IL-1\u03b2 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol. 2013;190:4196\u2013204.","journal-title":"J Immunol"},{"key":"1724_CR48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","volume":"61","author":"S Brandau","year":"2007","unstructured":"Brandau S, Suttmann H. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed Pharmacother. 2007;61:299\u2013305.","journal-title":"Biomed Pharmacother"},{"key":"1724_CR49","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","volume":"178","author":"MC Hall","year":"2007","unstructured":"Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178:2314\u201330.","journal-title":"J Urol"},{"key":"1724_CR50","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2217\/fon.14.79","volume":"10","author":"X Liu","year":"2014","unstructured":"Liu X, Dowell AC, Patel P, Viney RP, Foster MC, Porfiri E, et al. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Gu\u00e9rin. Future Oncol. 2014;10:1443\u201356.","journal-title":"Future Oncol"},{"key":"1724_CR51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)39365-5","volume":"144","author":"A B\u00f6hle","year":"1990","unstructured":"B\u00f6hle A, Gerdes J, Ulmer AJ, Hofstetter AG, Flad HD. Effects of local bacillus Calmette-Gu\u00e9rin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J Urol. 1990;144:53\u20138.","journal-title":"J Urol"},{"key":"1724_CR52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.urolonc.2007.11.031","volume":"26","author":"MP Simons","year":"2008","unstructured":"Simons MP, O\u2019Donnell MA, Griffith TS. Role of neutrophils in BCG immunotherapy for bladder cancer. Urol Oncol. 2008;26:341\u20135.","journal-title":"Urol Oncol"},{"key":"1724_CR53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.1995.155","volume":"71","author":"K Pryor","year":"1995","unstructured":"Pryor K, Goddard J, Goldstein D, Russell P, Golovsky D, Penny R. Bacillus Calmette-Gu\u00e9rin enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. Br J Cancer. 1995;71:801\u20137.","journal-title":"Br J Cancer"},{"key":"1724_CR54","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.173.5.3287","volume":"173","author":"HM Algood","year":"2004","unstructured":"Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol. 2004;173:3287\u201396.","journal-title":"J Immunol"},{"key":"1724_CR55","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.00595-10","volume":"55","author":"MA Groote De","year":"2011","unstructured":"De Groote MA, Gilliland JC, Wells CL, Brooks EJ, Woolhiser LK, Gruppo V, et al. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55:1237\u201347.","journal-title":"Antimicrob Agents Chemother"},{"key":"1724_CR56","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1128\/IAI.72.12.7084-7095.2004","volume":"72","author":"RH Copenhaver","year":"2004","unstructured":"Copenhaver RH, Sepulveda E, Armitige LY, Actor JK, Wanger A, Norris SJ, et al. A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infect Immun. 2004;72:7084\u201395.","journal-title":"Infect Immun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1724-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T21:09:28Z","timestamp":1568322568000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1724-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"article-number":"442"}}